These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1678106)

  • 1. Breast screening in women under 50.
    Kopans DB
    Lancet; 1991 Aug; 338(8764):447. PubMed ID: 1678106
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent results from the two Canadian breast screening trials.
    Duffy SW
    J Med Screen; 2014 Jun; 21(2):59-60. PubMed ID: 24907360
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of future breast cancer risk.
    Engstrom PF
    Cancer Epidemiol Biomarkers Prev; 1993; 2(1):1-2. PubMed ID: 8420605
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Whittemore AS
    J Natl Cancer Inst; 2005 Mar; 97(5):400; author reply 400-1. PubMed ID: 15741577
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer in Canada.
    Can Fam Physician; 1999 Aug; 45():1937-9, 1942-4. PubMed ID: 10463094
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women.
    Zakaria D; Shaw A
    Cancer Causes Control; 2019 Feb; 30(2):137-147. PubMed ID: 30637599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of modelling mammography screening strategies.
    Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
    Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor size distribution of invasive breast cancers and the sensitivity of screening methods in the Canadian National Breast Screening Study.
    Shaevitch D; Taghipour S; Miller AB; Montgomery N; Harvey B
    J Cancer Res Ther; 2017; 13(3):562-569. PubMed ID: 28862227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limitation of ACRIN DMIST.
    Hixson GL; Hendrick RE; Pisano ED; Yaffe MJ; Gatsonis CA
    Radiology; 2008 Aug; 248(2):702; author reply 702-3. PubMed ID: 18641261
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening younger women at risk for breast cancer.
    Vogel VG
    J Natl Cancer Inst Monogr; 1994; (16):55-60. PubMed ID: 7999470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends in breast cancer screening rates in the OECD countries.
    Saika K; Sobue T
    Jpn J Clin Oncol; 2011 Apr; 41(4):591-2. PubMed ID: 21447696
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Benefits and risks of screening mammography for women in their forties: a statistical appraisal.
    Kopans DB; Halpern E
    J Natl Cancer Inst; 1999 Feb; 91(4):382-4. PubMed ID: 10050875
    [No Abstract]   [Full Text] [Related]  

  • 16. DMIST results: technologic or observer variability?
    Kopans DB; Pisano ED; Acharyya S; Hendrick RE; Yaffe MJ; Conant EF; Fajardo LL; Bassett LW; Baum JK; Gatsonis CA
    Radiology; 2008 Aug; 248(2):703; author reply 703. PubMed ID: 18641262
    [No Abstract]   [Full Text] [Related]  

  • 17. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Canadian study of mammography screening and mortality from breast cancer.
    Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
    Berg WA; Bandos AI; Mendelson EB; Lehrer D; Jong RA; Pisano ED
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mammography as a breast cancer screening tool in six districts in France.
    Lacour A; Mamelle N; Lafont S; Bazin B; Dubuc M; Exbrayat C; Trugeon A; Grosclaude P
    Cancer Detect Prev; 1997; 21(5):460-70. PubMed ID: 9307849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.